Popular on EntSun
- Sea Tales Strengthens U.S. Leadership Team as Retail Expansion Accelerates - 393
- Stitt Entertainment Names Tristan Xavier Lead Stylist - 328
- ChargeOn Announces Conversational Payment Management Solution - 318
- Mecca to Mars: Earth's Escape? - 229
- Phinge Exposes Massive AI Security Risks, Claiming Its Patented Hardware-Verified Architecture Is The Only Safeguard Against Surveillance Capitalism - 215
- Robert DeMaio, Phinge CEO to Speak at 30th IIPLA 2026 on Securing IP, User Data & Digital Sovereignty via Verified App-less Tech. Attend the Live Q&A! - 212
- Rehearsals Begin on 'The Call List' by Brian James Polak - 196
- Free JavaScript Charting Library ProEssentialsJS Permits Commercial Use. Highcharts, SciChart and LightningChart Free Tiers Do Not - 190
- Volant Announces Major Partnership with the STEM Racing Canada Program to CHAMPION YOUTH ENGINEERING - 184
- Big Panic Records Announces "African Sunshine" by Believe, Shirley Jones & Omasta - 179
Similar on EntSun
- FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
- Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
- Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
- Mandeville Pests May Pose Serious Health Risks for Your Family
- Parents No Longer Have to Wait 3 Weeks for a Sleep Consultant: Nora Talks Tonight, Stays for 5 Days, Costs $89
- Black Women Living With, and Impacted by, HIV Express Gratitude, Grief, Joy, and Resilience
- Amaris Mint® Confirms UK Availability of Swedish-Made BioBoost Daily Nutrition Range
- Redefining Proactive Care: The Rise of the Hybrid Concierge Medical Model
- Mito Health Passes One Million Lab Tests, Expands to Seven Categories of Preventive Health Testing
- Vegan Kingz Unveils Upgraded Digital Platform to Streamline Commercial Foodservice & Wholesale Ordering
Accel Research Sites now recruiting for new pediatric COVID-19 vaccine trial
EntSun News/10876583
LAKE MARY, Fla. - EntSun -- Accel Research Sites will serve as a location for a new clinical trial for a COVID-19 vaccine candidate—this time for children.
The company is now recruiting those younger than 18 to participate. Enrollment will start soon.
The studies will take place at Accel's DeLand, Fla., and Lakeland, Fla., locations. Dr. Bruce Rankin and Dr. James Andersen will serve as the primary investigators.
"We're so proud to have played a part in developing vaccines for COVID-19," said Lora Parahovnik, CEO of Accel Research Sites. "Now, we want to play a part in helping everyone get vaccinated. These pediatric trials will be essential in developing a safe vaccine for those under 18."
Parents or guardians who are interested in having their children participate in the study can visit covidorlando.com (http://www.covidorlando.com). An Accel staff member will reach out to further evaluate eligibility
More on EntSun News
Accel Research Sites seeks to enroll a wide variety of participants for the trials, including racial and ethnic minorities. The company is also still recruiting for other COVID-19-related trials.
Accel Research Sites provides novel treatment options in all major therapeutic areas. It has more than 30 locations, including a 62-bed Phase 1 unit in Florida and units in Georgia and Alabama.
For more information about Accel Research Sites, visit accelresearchsites.com.
About Accel Research Sites
Accel Research Sites is a multi-therapeutic network of clinical research sites dedicated to the expert delivery of treatment options to patients and providers. They partner with the most innovative and significant pharmaceutical, biotechnology, and medical device companies worldwide to advance healthcare and wellness in the communities they serve.
The company is now recruiting those younger than 18 to participate. Enrollment will start soon.
The studies will take place at Accel's DeLand, Fla., and Lakeland, Fla., locations. Dr. Bruce Rankin and Dr. James Andersen will serve as the primary investigators.
"We're so proud to have played a part in developing vaccines for COVID-19," said Lora Parahovnik, CEO of Accel Research Sites. "Now, we want to play a part in helping everyone get vaccinated. These pediatric trials will be essential in developing a safe vaccine for those under 18."
Parents or guardians who are interested in having their children participate in the study can visit covidorlando.com (http://www.covidorlando.com). An Accel staff member will reach out to further evaluate eligibility
More on EntSun News
- Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
- Dwayne Buckle's Visionary 3D Feature Film Explores Power, Corruption, Truth & the Future of Humanity
- 360 Sound And Vision, 3D Dreams And Filmmaker Dwayne Buckle Unveil First Official Posters For The Glasses 3D
- Shelter Structures America makes European debut at TEMPOR EXPO 2026 in Fulda, Germany
- HydroExcavation.com Relaunches With Exclusive Local Service Areas and Dedicated Hydrovac Manufacturer Directory
Accel Research Sites seeks to enroll a wide variety of participants for the trials, including racial and ethnic minorities. The company is also still recruiting for other COVID-19-related trials.
Accel Research Sites provides novel treatment options in all major therapeutic areas. It has more than 30 locations, including a 62-bed Phase 1 unit in Florida and units in Georgia and Alabama.
For more information about Accel Research Sites, visit accelresearchsites.com.
About Accel Research Sites
Accel Research Sites is a multi-therapeutic network of clinical research sites dedicated to the expert delivery of treatment options to patients and providers. They partner with the most innovative and significant pharmaceutical, biotechnology, and medical device companies worldwide to advance healthcare and wellness in the communities they serve.
Source: Accel Research Sites
0 Comments
Latest on EntSun News
- Antoine Morgan steps into the "MARRIAGE BOX" and Things are getting interesting!
- French Camp Academy Releases New Video Inviting Individuals to Consider a Life of Service
- LET US READ Documentary on Dyslexia and Literacy to Screen at TCL Chinese 6 in Hollywood
- Don Barnhart Brings His NFTG Tour Home as Delirious Celebrates One Year at Silver Sevens
- Defense & Space Strategy Strengthens as New Leadership Builds on NASA Results and Expanding Multi-Orbit Opportunities for Ascent Solar Technologies
- Suits & Shoot Returns for 3rd Annual Noir Affair
- 'The Last Howl' Documentary Advocates for Conservation and Wildlife Preservation
- Venice FF 2026, Samantha Casella screens The Serpent's Caress
- 8th Edition of Filming Italy Venice Awards Cinema Talent
- STS Capital Partners is pleased to announce the appointment of Barry Brown as Vice President, Business Development
- Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
- Heritage at Manalapan Welcomes New Sales Team as Luxury Single-Family Home Community Continues to Grow
- Mandeville Pests May Pose Serious Health Risks for Your Family
- The Hot Sardines Return to Frederick for a Night of Vintage Jazz at the Weinberg Center
- Share your workplace safety solutions at 2027 Applied Ergonomics Conference
- Parents No Longer Have to Wait 3 Weeks for a Sleep Consultant: Nora Talks Tonight, Stays for 5 Days, Costs $89
- May The Worst Team Win! Loserball Kicks Off Another NFL Season of Hilarious Mayhem
- Anti-Bullying Film The Karate Weirdo Secures Global Streaming Acquisition
- Black Women Living With, and Impacted by, HIV Express Gratitude, Grief, Joy, and Resilience
- MainConcept Easy Video API Extends Full Transcoding to Arm and NETINT VPUs